A Study of Barzolvolimab in Patients With Prurigo Nodularis

NCT06366750 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Prurigo Nodularis

Interventions

BIOLOGICAL: barzolvolimab
OTHER: Matching Placebo

Sponsor

Celldex Therapeutics